These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25532040)

  • 1. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS; Birkebaek NH; Bjerre M; Pociot F; Kristensen K; Hoejberg AS; Frystyk J;
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dimorphism in growth and insulin-like growth factor-I in children with type 1 diabetes mellitus.
    Bizzarri C; Benevento D; Giannone G; Bongiovanni M; Anziano M; Patera IP; Cappa M; Cianfarani S
    Growth Horm IGF Res; 2014 Dec; 24(6):256-9. PubMed ID: 25175911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment.
    Strasser-Vogel B; Blum WF; Past R; Kessler U; Hoeflich A; Meiler B; Kiess W
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1207-13. PubMed ID: 7536202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
    J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
    Street ME; Smerieri A; Montanini L; Predieri B; Iughetti L; Valenzise M; De Luca F; Vigone M; Weber G; Maghnie M; Bernasconi S
    J Biol Regul Homeost Agents; 2013; 27(1):259-66. PubMed ID: 23489706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents.
    Hyun SE; Lee BC; Suh BK; Chung SC; Ko CW; Kim HS; Lee KH; Yang SW; Shin CH; Hwang JS; Kim DH; Lim BK; Kim JD; Yoo HW; Kim HS; Chung WY; Park MJ; Woo YJ; Kim CJ; Lee DY; Kim EY; Choi JH; Han HS; Hwang IT; Kim HS
    Clin Biochem; 2012 Jan; 45(1-2):16-21. PubMed ID: 22032863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
    Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
    Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.